Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Barwick

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Blood|April 10, 2024
NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenomeAmin Sobh, Elena Encinas, Alisha Patel, et al.
Blood Cancer Discovery|November 7, 2023
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple MyelomaPaola Neri, Benjamin G Barwick, David Jung, et al.
Blood Neoplasia|June 2, 2025
Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myelomaPriya Choudhry, Corynn Kasap, Bonell Patiño-Escobar, et al.
Blood Neoplasia|June 24, 2025
Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myelomaRudra P Dutta, Santiago Thibaud, Violetta Leshchenko, et al.
Blood|December 18, 2024
Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesisRemya Nair, An H Vu, Abigail K Freer, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myelomaNikhil Chilakapati, Bonell Patiño-Escobar, Emily Y Chen, et al.
Genome Biology|April 30, 2021
Ten-eleven translocation protein 1 modulates medulloblastoma progressionHyerim Kim, Yunhee Kang, Yujing Li, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Blood Cancer Discovery|September 28, 2023
Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple MyelomaSeth J Welsh, Benjamin G Barwick, Erin W Meermeier, et al.
Blood|May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Blood|April 10, 2024
NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenomeAmin Sobh, Elena Encinas, Alisha Patel, et al.
Blood Cancer Discovery|November 7, 2023
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple MyelomaPaola Neri, Benjamin G Barwick, David Jung, et al.
Blood Neoplasia|June 2, 2025
Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myelomaPriya Choudhry, Corynn Kasap, Bonell Patiño-Escobar, et al.
Blood Neoplasia|June 24, 2025
Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myelomaRudra P Dutta, Santiago Thibaud, Violetta Leshchenko, et al.
Blood|December 18, 2024
Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesisRemya Nair, An H Vu, Abigail K Freer, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myelomaNikhil Chilakapati, Bonell Patiño-Escobar, Emily Y Chen, et al.
Genome Biology|April 30, 2021
Ten-eleven translocation protein 1 modulates medulloblastoma progressionHyerim Kim, Yunhee Kang, Yujing Li, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Blood Cancer Discovery|September 28, 2023
Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple MyelomaSeth J Welsh, Benjamin G Barwick, Erin W Meermeier, et al.
Blood|May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Pageof 7